Tempus AI (TEM)
Coverage summary
Aardvark Labs Capital Research has covered Tempus AI (TEM) since May 6, 2026. The company is in the Healthcare sector. This page lists 3 reports: 3 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published November 5, 2026. The current rating is Hold, the same in every report since coverage began.
Translations: 2 in Chinese.
All TEM reports
2026-11-05
Recap: Q3 2026
Real Leverage at Last: Record EBITDA and Positive Operating Cash, Against a Multiple That Re-Rated 51% in Eleven Weeks
2026-08-19
Recap: Q2 2026
The First Profitable Quarter Tempus Didn't Earn: $8M of EBITDA, a $98M Mark, and a Back-Half That Has to Do 92% of the Work
2026-05-06
Recap: Q1 2026
Diagnostics Delivers, but Data Growth Still Needs to Earn Its Valuation